Codexis to Present at 2013 UBS Global Healthcare Conference 2013 UBS Global Healthcare Conference Business Wire REDWOOD CITY, Calif. -- May 14, 2013 Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET in New York City. A live webcast and replay will be available on the Investors section of the company's website, http://ir.codexis.com/. About Codexis, Inc. Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical production. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com. Contact: Codexis, Inc. Investors Paul Cox, 212-362-1200 email@example.com or Media Jemma Connor, +44 161 359 3255 firstname.lastname@example.org
Codexis to Present at 2013 UBS Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.